Cargando…

Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC

PURPOSE: Long non-coding RNA (lncRNA) SPRY4 intronic transcript 1 (SPRY4-IT1) is reported to play important roles in the occurrence and development of many tumors. However, the possible role of SPRY4-IT1 in cisplatin (DDP) resistance of non-small-cell lung cancer (NSCLC) remains unclear. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yunyao, Gu, Jingyao, Liu, Pei, Wang, He, Jiang, Lihua, Lei, Tianyao, Yu, Shanxun, Han, Gaohua, Wang, Zhaoxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135170/ https://www.ncbi.nlm.nih.gov/pubmed/32308413 http://dx.doi.org/10.2147/OTT.S232769

Ejemplares similares

Long noncoding RNA actin filament‐associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine‐specific demethylase 1 and repressing HMG box‐containing protein 1 in non‐small‐cell lung cancer
por: Yu, Shanxun, et al.
Publicado: (2019)

Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
por: Chen, Zhenyao, et al.
Publicado: (2020)

Cisplatin loaded multiwalled carbon nanotubes reverse drug resistance in NSCLC by inhibiting EMT
por: Qi, Yuxin, et al.
Publicado: (2021)

MPZL1 promotes tumor cell proliferation and migration via activation of Src kinase in ovarian cancer
por: Chen, Danni, et al.
Publicado: (2019)

Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer
por: Xu, Tianwei, et al.
Publicado: (2019)

LncRNA TNFRSF10A-AS1 promotes gastric cancer by directly binding to oncogenic MPZL1 and is associated with patient outcome
por: Sun, Donglei, et al.
Publicado: (2022)

Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression
por: Yang, Liang, et al.
Publicado: (2016)

Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells
por: Yang, Daolu, et al.
Publicado: (2021)

MicroRNA-21-3p accelerates diabetic wound healing in mice by downregulating SPRY1
por: Wu, Yaohong, et al.
Publicado: (2020)

Loss of Mpzl3 Function Causes Various Skin Abnormalities and Greatly Reduced Adipose Depots
por: Leiva, Angel G., et al.
Publicado: (2014)

Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell
por: Li, Yanfei, et al.
Publicado: (2022)

MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBC-SD cells
por: Liu, Xiaolei, et al.
Publicado: (2019)

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer: HMGB1-mediated autophagy promotes gefitinib resistance
por: Lei, Tianyao, et al.
Publicado: (2022)

Circ_0099630 Participates in SPRY1-Mediated Repression in Periodontitis
por: Wang, Jing, et al.
Publicado: (2022)

Met–HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells
por: Stern, Yaakov E., et al.
Publicado: (2022)

Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
por: Feng, Jian, et al.
Publicado: (2014)

FOXM1 Regulated by ERK Pathway MediatesTGF-β1-Induced EMT in NSCLC
por: Kong, Fei-Fei, et al.
Publicado: (2014)

MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A
por: Wang, Jin, et al.
Publicado: (2021)

Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab
por: Villalobos, Matthias, et al.
Publicado: (2019)

A Review on the Role of SPRY4-IT1 in the Carcinogenesis
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Antisense oligonucleotide‐mediated knockdown of Mpzl3 attenuates the negative metabolic effects of diet‐induced obesity in mice
por: Worley, Beth L., et al.
Publicado: (2021)

MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells
por: Beigbeder, Alice, et al.
Publicado: (2017)

Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours
por: Das, Mrinal K., et al.
Publicado: (2018)

Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis
por: Wang, Miaojuan, et al.
Publicado: (2017)

PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC
por: Racherla, Kavya Sri, et al.
Publicado: (2023)

Mr. Spry's Case of Poison
por: Spry, James Hume
Publicado: (1800)

Mr. Spry, on Morbid Anatomy
por: Spry, T. H.
Publicado: (1800)

Mr. Spry's Case of Hernia
por: Spry, James Hume
Publicado: (1801)

A novel MPZL2 c.68delC variant is associated with progressive hearing loss in Chinese population and literature review
por: Wang, Zhili, et al.
Publicado: (2022)

An Array SPRi Biosensor for the Determination on PARP-1 in Blood Plasma
por: Zielinska, Zuzanna, et al.
Publicado: (2023)

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
por: Vance, Stephen, et al.
Publicado: (2016)

Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2
por: Cui, Shuaishuai, et al.
Publicado: (2023)

Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition
por: Shen, Fei, et al.
Publicado: (2016)

EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition
por: Sun, M, et al.
Publicado: (2014)

Spry1 and Spry4 Differentially Regulate Human Aortic Smooth Muscle Cell Phenotype via Akt/FoxO/Myocardin Signaling
por: Yang, Xuehui, et al.
Publicado: (2013)

Enhanced nuclear localization of YAP1‐2 contributes to EGF‐induced EMT in NSCLC
por: Guo, Qiang, et al.
Publicado: (2022)

Up-regulation of long non-coding RNA SPRY4-IT1 promotes tumor cell migration and invasion in lung adenocarcinoma
por: Zhang, Xia, et al.
Publicado: (2017)

Kidney Development in the Absence of Gdnf and Spry1 Requires Fgf10
por: Michos, Odyssé, et al.
Publicado: (2010)

Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer
por: Tan, Wenlong, et al.
Publicado: (2017)

A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer
por: Huang, Renhong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l03up7crt401k37d607qa3ojn5